These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 725115)
41. [Smoking and cardiopulmonary function. 5. VA/Q inequality in smokers (author's transl)]. Kato M Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Sep; 15(9):580-8. PubMed ID: 592571 [No Abstract] [Full Text] [Related]
42. [Secondary polyglobulism in chronic obstructive lung disease and hydrochloric acid secretion in the stomach (author's transl)]. Dolinský A Cas Lek Cesk; 1975 Nov; 114(46):1429-33. PubMed ID: 1203927 [No Abstract] [Full Text] [Related]
43. [A study on prognosis of chronic obstructive lung disease with reference to clinical types (author's transl)]. Sadakane A Nihon Naika Gakkai Zasshi; 1975 Jul; 64(7):661-8. PubMed ID: 1238490 [No Abstract] [Full Text] [Related]
44. An overview of obstructive lung diseases. Burrows B Med Clin North Am; 1981 May; 65(3):455-71. PubMed ID: 7242173 [No Abstract] [Full Text] [Related]
45. IgE, smoking and lung function. Villar T; Holgates T Clin Exp Allergy; 1994 Jun; 24(6):508-10. PubMed ID: 7922770 [No Abstract] [Full Text] [Related]
46. Increased levels of airways responsiveness as a risk factor for development of chronic obstructive lung disease. What are the issues? Weiss ST; Speizer FE Chest; 1984 Jul; 86(1):3-4. PubMed ID: 6734287 [No Abstract] [Full Text] [Related]
47. [Optimal frequencies of breathing in patients with chronic obstructive pulmonary disease (author's transl)]. Irie T Nihon Naika Gakkai Zasshi; 1973 Nov; 62(11):1529-38. PubMed ID: 4799611 [No Abstract] [Full Text] [Related]
48. [Results with a new method of rapid estimation of residual volume (author's transl)]. Kowalski J; Quanjer PH; Laros CD; Foest KA; Visser BF Pneumonologie; 1973 Dec; 149(3):199-204. PubMed ID: 4779646 [No Abstract] [Full Text] [Related]
49. [Problems of clinical respiratory physiology. Report on a symposium convened by the Ministry of Health of the USSR in Leningrad/USSR, October 1973 (author's transl)]. Barth JA Z Erkr Atmungsorgane; 1977; 148(2):249-54. PubMed ID: 21491 [No Abstract] [Full Text] [Related]
50. [The clinical utility of measuring the health-related quality of life]. Sobradillo Peña V; Casan P Arch Bronconeumol; 1995 May; 31(5):197-8. PubMed ID: 7788079 [No Abstract] [Full Text] [Related]
52. Muscle mass and strength in obstructive lung disease: a smoking gun? Kon SS; Man WD Thorax; 2011 Nov; 66(11):933-5. PubMed ID: 21813620 [No Abstract] [Full Text] [Related]
53. IgE, smoking and lung function. Villar MT; Holgate ST Clin Exp Allergy; 1995 Mar; 25(3):206-9. PubMed ID: 7788566 [No Abstract] [Full Text] [Related]
54. HIV infection and lung function decline: challenges, clinical implications, and new questions. Crothers K; Morris A AIDS; 2013 May; 27(8):1345-7. PubMed ID: 23925381 [No Abstract] [Full Text] [Related]
56. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Islam SS; Schottenfeld D Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576 [TBL] [Abstract][Full Text] [Related]
57. [Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)]. Sprung J Plucne Bolesti Tuberk; 1981; 33(1):8-13. PubMed ID: 7244024 [No Abstract] [Full Text] [Related]